Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 950 participants.
Also called NCT03252626
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 950 participants
- Registry
-
NCT03252626
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03252626. Randomized; triple masking; primary purpose treatment. Start 2024-04-18 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
- Condition
- Stroke
- Intervention (Drug)
- Alprostadil
- Intervention (Drug)
- Normal saline
- Lead sponsor
- The First Hospital of Jilin University
Record details
- Record id
cardio:ct-nct03252626- Content hash
7ca1bf0896ead34d0040177e42738f852657db842e94e297db4219127e61839f